Atherosclerosis is the primary cause of cardiovascular disease, and the ris
k for atherosclerosis is inversely proportional to circulating levels of hi
gh-density lipoprotein (HDL) cholesterol. However, the mechanisms by which
HDL is atheroprotective are complex and not well understood(1,2), Here we s
how that HDL stimulates endothelial nitric oxide synthase (eNOS) in culture
d endothelial cells. In contrast, eNOS is not activated by purified forms o
f the major HDL apolipoproteins ApoA-I and ApoA-II or by low-density lipopr
otein. Heterologous expression experiments in Chinese hamster ovary cells r
eveal that scavenger receptor-BI (SR-BI) mediates the effects of HDL on the
enzyme. HDL activation of eNOS is demonstrable in isolated endothelial-cel
l caveolae where SR-BI and eNOS are colocalized, and the response in isolat
ed plasma membranes is blocked by antibodies to ApoA-I and SR-BI, but not b
y antibody to ApoA-II. HDL also enhances endothelium- and nitric-oxide-depe
ndent relaxation in aortae from wild-type mice, but not in aortae from homo
zygous null SR-BI knockout mice. Thus, HDL activates eNOS via SR-BI through
a process that requires ApoA-I binding. The resulting increase in nitric-o
xide production might be critical to the atheroprotective properties of HDL
and ApoA-I.